PMCTPharmaCountry
    Home

PRIORIX, poudre et solvant pour solution injectable en seringue préremplie. Vaccin rougeoleux, des oreillons et rubéoleux vivant

GlaxoSmithKline
GlaxoSmithKline
Manufacturer · Finished Dosage FormsFlag of USUnited States
Rx

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Powders / Oral Powders/Sachets

Trade Type

Sell

Product Name

PRIORIX, poudre et solvant pour solution injectable en seringue préremplie. Vaccin rougeoleux, des oreillons et rubéoleux vivant

Details

VIRUS DES OREILLONS (SOUCHE RIT 4385 DERIVÉE DE LA SOUCHE JERYL LYNN) ATTENUÉ au minimum 10^3,7 DICC50 • VIRUS DE LA ROUGEOLE, SOUCHE SCHWARTZ, VIVANT, ATTÉNUÉ au minimum 10^3,0 DICC50 • VIRUS RUBÉOLEUX (SOUCHE WISTAR RA 27/3) ATTÉNUÉ au minimum 10^3,0 DICC50

Substance

VIRUS DES OREILLONS (SOUCHE RIT 4385 DERIVÉE DE LA SOUCHE JERYL LYNN) ATTENUÉ • VIRUS DE LA ROUGEOLE, SOUCHE SCHWARTZ, VIVANT, ATTÉNUÉ • VIRUS RUBÉOLEUX (SOUCHE WISTAR RA 27/3) ATTÉNUÉ

Registered Market

Specifications

  • Dosage Form: Powder
  • Packaging: 1 bottle(s) in glass of 1 dose(s) - 1 syringe(s) pre-filled(s) in glass of 0,5 ml with 2 needle(s)

Documents

Drug Marketing Authorization Number
Document No.: 61896473
Issue Date: May 25, 1999
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Explore More

Similar Products & Services

Products & Services related to what you're viewing

Explore More

People Also Viewed

Other products & services viewed by people who looked at this product

Discover More